GTY (GTY)

$1.9B
Market Cap
23.6
P/E Ratio
0.85
Beta
6.11%
Dividend Yield
Piotroski 6/9Altman Z 1.1 DistressBeneish M -2.61 CleanROIC−WACC -3.0%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9, Altman Z 1.1.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics reveal a capital allocation challenge despite robust profitability metrics. While the DuPont decomposition highlights exceptional net margins of 35.7% driven by high gross yields, this strength is offset by low asset turnover and an ROIC-WACC spread of -3.0%, indicating that current returns on invested capital fail to cover the cost of financing. This structural inefficiency is underscored by a deteriorating balance sheet profile; an Altman Z-Score of 1.1 signals elevated bankruptcy risk, contrasting with a relatively strong Beneish M-Score of -2.61 and a solid Piotroski F-Score of 6/9 which suggests stable fundamentals without obvious earnings manipulation.

Valuation analysis presents a divergence between market pricing and intrinsic value models. Trading at a forward P/E of 23.6x, the stock commands a premium relative to its implied growth trajectory when weighed against a DCF fair value estimate of $44. The market appears willing to price in continued expansion given the 9.0% revenue growth YoY, yet this multiple may not fully account for the capital efficiency drag evident in the negative ROIC spread and liquidity concerns flagged by the Altman metric.

With insider flow remaining neutral over the past ninety days, there is no immediate signal of management conviction or distress driving share supply dynamics. The risk/reward profile hinges on whether operational improvements can close the gap between current asset utilization and the cost of capital, as the combination of high financial leverage (equity multiplier of 2.03x) and a Z-Score below 1.8 creates potential downside volatility that must be weighed against the attractive margin expansion story.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6.4%8.4%10.4%
2%$60$37$25
3%$79$44$29
4%$114$55$34

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=8.4%, terminal growth 3%. Fair value $44 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
1.1
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.61
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

96.1%
Gross Margin
35.7%
Net Margin
5.4%
ROIC
8.4%
WACC
ROIC − WACC Spread: -3.0%— Negative spread.
+9.0%
Revenue Growth (YoY)
+11.4%
Earnings Growth (YoY)
127.0M
Free Cash Flow
86%
FCF Payout Ratio

⚠️ Dividend consumes >80% of FCF — sustainability risk.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

35.7%
Net Profit Margin
NI ÷ Revenue
×
0.10x
Asset Turnover
Revenue ÷ Assets
×
2.03x
Equity Multiplier
Assets ÷ Equity
=
7.4%
Return on Equity
✅ ROE driven primarily by strong profit margins — a sign of pricing power.

Balance Sheet Health

1.03x
Debt / Equity
0.33x
Current Ratio
2.7x
Interest Coverage
3.9x
Net Debt / EBITDA
4.80%
FCF Yield
189.0M
EBITDA

Earnings Surprise History

Q4
✗ Miss
Est: $0.31
Act: $0.26
-15.6%
Q3
✗ Miss
Est: $0.33
Act: $0.33
-0.6%
Q2
✓ Beat
Est: $0.34
Act: $0.36
+5.8%
Q1
✓ Beat
Est: $0.34
Act: $0.40
+16.4%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

21.3
Forward P/E
PEG Ratio
1.78
Price/Book
560605
Avg Volume
$34.14
52W High
$25.39
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$93M
Tracked Passive Exposure
6
ETFs Holding GTY
0.09%
Avg Weight in ETFs
$101B
Total ETF AUM

When investors buy or sell ETFs like VFMV or SLYG, the fund manager is mechanically forced to buy or sell GTY shares regardless of GTY's individual fundamentals. We estimate $93M of passive capital is structurally linked to GTY through 6 tracked ETFs. Passive flows have a limited but growing influence on GTY's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 6 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in GTY to visualize passive redemption contagion across ETFs and collateral stocks.

GTY Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
GTYEpicenterVNQETFSPSMETFSPTMETFVRTPXUnknownWELLLow RiskPLDMed RiskEQIXMed RiskAMTHigh Risk
GTY Price Drop (%)0

If GTY (GTY) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Vanguard Real Estate II Index Fund Institutional Plus Shares (VRTPX) as the most exposed collateral stock, sharing 1 ETFs with GTY. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 6 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

GTY Ownership Dynamics

Ticker
GTY

Float lock-up computed from 6 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

GTY Capital Efficiency

How efficiently does GTY convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$127M
EBITDA
$189M
FCF Conversion
67%
Reinvestment Rate
33%
67% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
5.4%
ROIC − WACC Spread
-3.0%

GTY converts 67% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-3.0%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1466$32.50$2,145
2026-05-1239$33.00$1,287
2026-05-0564$32.99$2,111.36
2026-04-277,424$33.45$248,332.8
2026-04-1533$33.70$1,112.1
2026-03-3182$31.83$2,610.06
2026-03-25718$32.31$23,198.58
2026-03-1749$33.70$1,651.3
2026-03-03200$33.13$6,626
2026-02-252,000$32.61$65,220
2026-02-1920$31.41$628.2
2026-02-13155$33.02$5,118.1
2026-02-06168$31.22$5,244.96
2026-01-2915$28.80$432
2026-01-28174$29.45$5,124.3
2025-12-3134$27.33$929.22
2025-12-29391$27.58$10,783.78
2025-12-23132$28.19$3,721.08
2025-12-101,178$28.22$33,243.16
2025-12-081,742$27.93$48,654.06
2025-11-131$27.39$27.39
2025-11-10149$27.31$4,069.19
2025-11-04230$27.35$6,290.5
2025-10-31205$27.56$5,649.8
2025-10-2722$27.89$613.58
2025-10-2368$27.53$1,872.04
2025-10-2021$27.17$570.57
2025-10-163,552$26.25$93,240
2025-10-14672$25.61$17,209.92
2025-10-101,205$25.79$31,076.95

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare GTY to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.